Viktor Kharitonin Net Worth (2025)
Businessman, Pharmaceutical Entrepreneur
Net Worth
Wealth Tier: Billionaire
Net worth between $1 billion and $10 billion
Annual Income
$50 million annually from business dividends
Net Worth Timeline
2022: $1,900,000,000, 2023: $2,000,000,000, 2024: $2,400,000,000
Viktor Kharitonin's Biography
Viktor Kharitonin is a prominent Russian businessman and billionaire best known for co-founding Pharmstandard, one of Russia’s largest pharmaceutical companies. Born on May 10, 1972, Kharitonin graduated from Moscow State University and quickly became a key player in the Russian pharma industry. His major breakthrough came in 2003 with the foundation of Pharmstandard, which soon launched Arbidol, a popular painkiller and antiviral drug in Russia. Under his leadership, Pharmstandard grew rapidly, making Kharitonin one of the wealthiest individuals in the country. Beyond pharmaceuticals, Viktor Kharitonin has diversified his interests into motorsports, notably acquiring a significant stake in the historic Nürburgring racetrack in Germany. Despite his wealth, Kharitonin maintains a low public profile, rarely appearing in the media and keeping his personal life private. As of 2024, his estimated net worth stands at $2.4 billion, according to Forbes. Known for his keen business sense and investments in both healthcare and automotive sectors, Kharitonin is recognized as a visionary in Russian industry. His interests span innovation in medicine, motorsports, and classic car collection, reflecting his dynamic approach to both business and lifestyle.
Wealth in Perspective
Fun Fact
He is a co-owner of Germany’s iconic Nürburgring racing circuit.
Full Name
Viktor Kharitonin
Nickname
Viktor
Nationality
Russian
Birthday
May 10, 1972
Age
53
Zodiac Sign
Taurus
Height
180 cm cm
Weight
85 kg kg
Marital Status
Married
Spouse
Unknown
Children
2
Education
Moscow State University
Famous For
Co-founding Pharmstandard, one of Russia’s largest pharmaceutical companies
First Big Break
Co-founding Pharmstandard in 2003 and launching the successful painkiller Arbidol
Social Media
Not publicly available
Businesses Owned
Pharmstandard, Nizhpharm, shares in Nürburgring racetrack
Awards
Included in Forbes Russian Billionaires list
Category
Business
Controversies
Faced scrutiny due to business activities during Russian pharmaceutical market reforms
Hobbies
Motorsports, classic car collection
Interests
Pharmaceutical innovation, business investments, racing
Quote
Success in business is about vision and persistence.